Uncategorized

https://www.einnews.com/pr_news/578338641/ariz-precision-medicine-adds-h-michael-shepard-phd-to-the-company-s-scientific-advisory-board...

Read More

ARIZ Precision Medicine, The PRDM Oncogene Targeting Company™ announced that it has secured seed financing bringing total funding to date of $2.5 million. Proceeds will be used to expand the management team as well as continue development of its proprietary PRDM-based product candidates for lung ca...

Read More

DAVIS, California —September 21, 2020-- ARIZ Precision Medicine (ARIZ) today announced the promotion of Brad Niles, Ph.D. to the Chief Executive Officer (CEO) position.  Brad has previously served as ARIZ COO and VP of Research and Development since 2016.  Former CEO Lonnie Bookbinder wil...

Read More

http://califesciencesinstitute.org/fast-spring-2020-showcase-a-virtual-success/?utm_campaign=CLSA%20Bulletin&utm_medium=email&_hsmi=92289318&_hsenc=p2ANqtz-9oNCOUhD4NuhD9OTSKhtB6EROLGpBQC_Rji1gT1XSgGADIwHc6jUhCI4FBKszuX4QP3J69FMrLutp8y8UxCI_vFEmoyA&utm_content=92289318&utm_sour...

Read More

ARIZ Precision Medicine was honored to be selected as one of nine companies worldwide to participate in Johnson & Johnson Innovation’s Quick Pitch at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on January 14, 2020.  ARIZ CEO Lonnie Bookbinder presented information abo...

Read More

We've been featured in an article on Select Sacramento. ARIZ Precision Medicine is pioneering cancer research out of their lab in Davis. They’re working to create a safer alternative to chemotherapy by developing a drug that targets cancer cells. ARIZ modulates cancer-causing genes and proteins...

Read More